Latest News
New Australian Trials into Medicinal Cannabis
- There is limited evidence on the impact of medicinal cannabis on the quality of life of people with MS.
- There are currently two observational trials underway in Australia, looking to...
World Continence Week - MS Australia features in Bridge Magazine
This week is World Continence Week and the Continence Foundation of Australia has published their latest magazine ...
Reflecting on World MS Day 2021
Each year, World MS Day brings together the global MS community to raise awareness, advocate for better services and effective treatments, connect with research and build the MS community.
World MS Day focusses on a theme, and for 2020 – 2022 a three year Connections theme was...
MS recognised in Queen’s Birthday 2021 Honours List
Multiple sclerosis (MS) has been recognised in this year’s Queen’s Birthday Honours List, announced by the Governor-General of Australia on 14 June 2021.
We are delighted to...
WORLD MS DAY 2021: Australians encouraged to reach out and help address MS social isolation
Supercharging the MS agenda
In the lead up to World MS Day this Sunday 30 May, MS Australia hosted a special multiple sclerosis (MS) research and advocacy update with the Parliamentary Friends of MS,...
MS Australia's Response to the Federal Budget 2021-2022: Impact on the MS Community
This year’s budget returns us to the annual May budget cycle with a focus on the long-term, following last year’s short-term, essential, COVID-19 recovery budget, delivered in October 2020.
As expected, the 2021-22 Budget continues to make a major commitment to Australia’s COVID-19...
Motherhood and MS - Mary's Story
“Nobody wants to get a phone call from their doctor on Good Friday. It’s never good news.”
It was 1995, and 30-year-old Mary had been having strange sensations running through her body when she bent her neck. Suspecting either a spinal tumour or multiple...
New Atlas of MS identifies global gaps in MS clinical management
The MS International Federation has just launched the second part of its update to the Atlas of MS. This 3rd Edition of the Atlas examined clinical management...
Ofatumumab (Kesimpta) recommended for PBS subsidy
- Today, the Pharmaceutical Benefits Advisory Committee(PBAC) has announced their recommendation that ofatumumab be subsidised under the Pharmaceutical Benefit Scheme (PBS).
- In March 2021 the Therapeutic Good Administration (TGA) approved this medication for the treatment of...
Disability Transport Standards for Accessible Public Transport
MS Australia welcomes release of final Report of the Aged Care Royal Commission
MS Australia welcomes the release of the final Report of the Aged Care Royal Commission. We were very pleased to see that key recommendations in the Report closely align to the...